Rocket Lab Blasts Off on Record Earnings and $816M Contract Win

Signal: BUY | Score: 53.41/100

Rocket Lab just delivered a monster quarter and landed an $816M government contract, yet the stock sits 28% below its 52-week high. With Q1 guidance pointing to 57% revenue growth and a backlog that jumped 73% year-over-year, this aerospace darling is finally turning the corner on profitability.

The Setup

RKLB is trading at $71.93 with a neutral RSI of 49.9, giving us a clean technical entry without the frothy overbought conditions we've seen at the highs. The stock has found solid support in the $60s after cooling off from its October peak near $99. Volume has been steady, and with earnings not until May 7th, we have a clear runway without immediate event risk hanging over the position.

The Catalyst

The February 26th earnings drop was pure rocket fuel. Q4 2025 revenue hit a record $180M, pushing full-year 2025 to $602M (up 38% year-over-year) with a perfect 21-launch success rate. But here's the kicker - Q1 2026 guidance calls for $185M to $200M in revenue, representing 57% growth at the midpoint.

The real game-changer is that $816M Space Development Agency prime contract win. This isn't just another customer - it's the Pentagon betting big on Rocket Lab's capabilities. Combined with a backlog that exploded 73% to $1.85B and liquidity over $1B, management has unprecedented visibility into future growth.

Bull Case

Neutron rocket development progressing on schedule, which could 10x their launch capacity and compete directly with SpaceX
Government contracts expanding beyond NASA to include prime Defense Department deals, diversifying revenue streams
$1.85B backlog provides 3+ years of revenue visibility at current run rates, with 57% growth already guided for Q1

Bear Case

Margin compression to 34-36% GAAP as they scale operations and invest in Neutron development
High valuation metrics with forward P/E over 500x, leaving little room for execution missteps

The Trade

Entry: $71.93 (current market price)
Target: $89.88 (analyst consensus, 25% upside)
Stop Loss: $62.00 (below recent support, 14% risk)
Risk/Reward: 1.8:1
Timeframe: 3-6 months (ahead of May earnings catalyst)

*This is one person's analysis, not financial advice. Always do your own research.*